UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 5.501

Sortiert nach

Histologic and cytomorphologic features of ALK-rearranged lung adenocarcinomas

Modern pathology, 2012-11, Vol.25 (11), p.1462-1472

2012

Link zum Volltext

Verfügbarkeit prüfen

Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target

International journal of oncology, 2013-01, Vol.42 (1), p.44-54

2013

Link zum Volltext

Verfügbarkeit prüfen

Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid

The Journal of pathology, 2003-10, Vol.201 (2), p.229-237

2003

Link zum Volltext

Verfügbarkeit prüfen

Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (14), p.3922-3930

2017

Link zum Volltext

Verfügbarkeit prüfen

Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas

Journal of clinical oncology, 2017-09, Vol.35 (26), p.3065-3074

2017

Link zum Volltext

Verfügbarkeit prüfen

The m(6)A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells

Molecular cell, 2016-05, Vol.62 (3), p.335-345

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3327-3334

2013

Link zum Volltext

Verfügbarkeit prüfen

Correlation between chemosensitivity to anticancer drugs and telomerase reverse transcriptase mRNA expression in gastric cancer

Diagnostic pathology, 2013-02, Vol.8 (1), p.33-33, Article 33

2013

Link zum Volltext

Verfügbarkeit prüfen

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology

Journal of clinical oncology, 2017-02, Vol.35 (4), p.446-464

2017

Link zum Volltext

Verfügbarkeit prüfen

Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study

The lancet oncology, 2018-10, Vol.19 (10), p.1372-1384

2018

Link zum Volltext

Verfügbarkeit prüfen

Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models

Cancer research (Chicago, Ill.), 2007-05, Vol.67 (10), p.4933-4939

2007

Link zum Volltext

Verfügbarkeit prüfen

EGFR exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristics

Molecular cancer therapeutics, 2013-02, Vol.12 (2), p.220-229

2013

Link zum Volltext

Verfügbarkeit prüfen

Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas

Cancer discovery, 2013-06, Vol.3 (6), p.630-635

2013

Link zum Volltext

Verfügbarkeit prüfen

SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer

Nature (London), 2014-06, Vol.510 (7504), p.283-287

2014

Link zum Volltext

Verfügbarkeit prüfen

Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism

Science (American Association for the Advancement of Science), 2016-02, Vol.351 (6273), p.604-608

2016

Link zum Volltext

Verfügbarkeit prüfen

Legumain Expression in Relation to Clinicopathologic and Biological Variables in Colorectal Cancer

Clinical cancer research, 2005-03, Vol.11 (6), p.2293-2299

2005

Link zum Volltext

Verfügbarkeit prüfen

Intestinal PPARα Protects Against Colon Carcinogenesis via Regulation of Methyltransferases DNMT1 and PRMT6

Gastroenterology (New York, N.Y. 1943), 2019-09, Vol.157 (3), p.744-759.e4

2019

Link zum Volltext

Verfügbarkeit prüfen

Combination of chemotherapy and gefitinib as first‐line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial

International journal of cancer, 2017-09, Vol.141 (6), p.1249-1256

2017

Link zum Volltext

Verfügbarkeit prüfen

IDO is a nodal pathogenic driver of lung cancer and metastasis development

Cancer discovery, 2012-08, Vol.2 (8), p.722-735

2012

Link zum Volltext

Verfügbarkeit prüfen

Identification of DHODH as a therapeutic target in small cell lung cancer

Science translational medicine, 2019-11, Vol.11 (517)

2019

Link zum Volltext

Verfügbarkeit prüfen

Frequent DYRK2 gene amplification in micropapillary element of lung adenocarcinoma - an implication in progression in EGFR-mutated lung adenocarcinoma

Histology and histopathology, 2021-03, Vol.36 (3), p.305

2021

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project

Journal of clinical oncology, 2014-09, Vol.32 (25), p.2780-2787

2014

Link zum Volltext

Verfügbarkeit prüfen

The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients

Oncotarget, 2016-03, Vol.7 (11), p.12404-12413

2016

Link zum Volltext

Verfügbarkeit prüfen

Blockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells

Cancer letters, 2017-10, Vol.406, p.93-104

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 5.501

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.763)
Mit Volltextzugriff
(4.327)

Publikationsform

Sprache

13 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(5.498)
EZB Electronic Journals Library
(2.854)
IngentaConnect
(2.154)
Journals@Ovid Complete
(1.967)
Single Journals
(1.391)
Elsevier ScienceDirect Journals Complete
(946)
IngentaConnect Journals
(892)
Wiley Online Library
(779)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(731)
Wiley Online Library Full Collection 2018
(621)
Springer Online Journals Complete
(490)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(331)
Nature Journals Online
(293)
Oxford University Press Journals Current
(265)
Oxford Journals 2020 Medicine
(241)
Springer Book Series
(147)
Nexis Uni
(116)
Taylor & Francis Current Content Access
(109)
Taylor & Francis:Master (3349 titles)
(107)
SAGE Complete
(99)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Histologic and cytomorphologic features of ALK-rearranged lung adenocarcinomas

Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target

Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid

Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer

Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas

The m(6)A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

Correlation between chemosensitivity to anticancer drugs and telomerase reverse transcriptase mRNA expression in gastric cancer

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology

Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study

Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models

EGFR exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristics

Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas

SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer

Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism

Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition

Legumain Expression in Relation to Clinicopathologic and Biological Variables in Colorectal Cancer

Intestinal PPARα Protects Against Colon Carcinogenesis via Regulation of Methyltransferases DNMT1 and PRMT6

Combination of chemotherapy and gefitinib as first‐line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial

IDO is a nodal pathogenic driver of lung cancer and metastasis development

Identification of DHODH as a therapeutic target in small cell lung cancer

Frequent DYRK2 gene amplification in micropapillary element of lung adenocarcinoma - an implication in progression in EGFR-mutated lung adenocarcinoma

Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project

The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients

Blockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells

Suchergebnisse filtern